Creyon Bio

About:

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Website: https://creyonbio.com/

Twitter/X: creyonbio

Top Investors: Alexandria Venture Investments, Lux Capital, Casdin Capital, DCVC Bio, BioBrit

Description:

Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for generating uniquely powerful datasets and developing machine learning models to uncover the engineering principles that make precision oligonucleotide-based medicines possible for patient populations of all sizes.

Total Funding Amount:

$40M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)creyonbio.com

Founders:

Christopher Hart, Swagatam Mukhopadhyay

Number of Employees:

11-50

Last Funding Date:

2022-03-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai